News Releases

Germfree Announces Collaboration with Ori Biotech for Modular Facility Integration, Automation, and Scale Out for Cell and Gene Manufacturing

Philadelphia, PA and Ormond Beach, FL – June 15, 2020 –  Ori Biotech Ltd (Ori), an innovator in cell and gene therapy (CGT) manufacturing, and Germfree Laboratories Inc (Germfree), experts in providing process-ready, mobile and modular cleanrooms for CGT manufacturing today announced a collaboration partnership to create an intensified, manufacturing platform that will facilitate higher throughput in both centralized and decentralized CGT manufacturing models. “Ori Biotech continues to build partnerships with best-in-class expert suppliers across the cell and gene therapy ecosystem, like Germfree, to help enable our vision for a fully integrated, closed system manufacturing platform supporting the cell and gene therapy industry,” said Farlan Veraitch, Co-Founder and CSO, Ori Biotech. “Innovation that reduces the significant size and cost of cell and gene therapy manufacturing facilities is another step toward enabling our customers to bring their life saving treatments to patients at scale.” “Germfree has a long history of developing cleanroom technologies for specific applications based on tractor trailer and modular building platforms,” said Kevin Kyle, President, Germfree. “We are excited to be partnering with a ground-breaking company like Ori Biotech to deliver the vision of vein-to-vein point of care for personalized medicine delivery.” “With cost of building bricks and […]

Germfree Partners with HOK to Rapidly Deploy bioGO COVID-19 Testing Labs

Germfree partners with HOK to rapidly deploy US-based testing facilities to battle COVID-19. Utilizing state of the art manufacturing processes, Germfree and HOK are bringing robust BSL-2+ laboratories to market that will enable testing at a level not previously seen possible. University campuses, corporate campuses, business parks, and manufacturing facilities are provided full-time, high throughput testing capabilities via a space-efficient and convertible laboratory. These facilities, along with local governments, enable an expanding testing network to monitor disease transmission and protect communities nationwide. Protecting Communities, Advancing Global Health Enabling Scaled Local Testing At a Germfree/HOK bioGO facility, it is estimated an average of 240 samples per day can be self-collected by the participants. With additional guidance from telemedicine, a test-kit is provided to participants who are assisted by limited personnel in PPE. These facilities limit the need for large quantities of individuals in PPE to collect samples on the ‘frontline’ which will soon become the institutions that scores of individuals will be returning to work or learn. Up to 80 batches can be processed at a time in under 60 minutes with high-throughput testing platforms such as Cepheid GeneCpert Express, which will be available lab options. Process and registration information is […]

Building ‘Mission Essential Infrastructure’ for COVID-19 Response

US Biocontainment Manufacturer Delivers Mobile Unit for Work on Coronavirus Vaccine ORMOND BEACH, Fla. and LOUISVILLE, Ky., April 9, 2020 /PRNewswire/ — This week, Germfree delivered a 53-foot containment cleanroom trailer to a major US pharmaceutical company where they will work on a COVID-19 vaccine. This is the first, of what is expected to be, many mobile laboratory spaces that will be delivered to scientists and organizations working on virus and antibody testing, vaccine development, research, and deployment solutions. Germfree was quickly able to meet the need for a biocontainment unit specifically designed for COVID-19 vaccine development because the company has decades of experience providing rapidly deployable biocontainment laboratory space. Since the 1990s, the Germfree has pioneered the use of mobile containment cleanrooms for surge capacity, hospital renovations, and emergency preparedness. In recent years, the company has deployed over 60 mobile solutions like the ones needed to meet the COVID-19 crisis to public and private healthcare systems across the US, including to the National Institutes of Health (NIH), Massachusetts General Hospital, Stanford Health Care, Kaiser Permanente, UW Medicine, Yale New Haven Health, and the US Department of Veterans Affairs (VA). This experience positions Germfree to provide what is needed today […]

Bio-containment Labs Deployed to Fortify Capacity for Pandemic Response

Ormond Beach, FL, US – April 1st, 2020 – By mid-March, the emerging pandemic sounded alarms at the highest levels and Germfree was being asked to provide biological containment laboratories – fast. Calls came in from public health labs and researchers across the globe who work to contain local outbreaks and prevent regional epidemics. Now facing a pandemic, priorities shifted, and efforts intensified as did the need for bio-containment space. The global response to COVID-19 would reveal critical deficiencies in global laboratory capacity that now require fast, flexible solutions. “COVID-19 presents unprecedented challenges to our global laboratory infrastructure,” said Dr. Steven Jones, Associate Provost for Health Sciences at the University of Saskatchewan and co-discoverer of a vaccine for Ebola. Jones has confronted these concerns with previous coronavirus outbreaks. “Our laboratory capabilities must be agile and responsive to potential biological threats in a wide range of scenarios. In 2014, I worked with Germfree to quickly deploy one of their laboratories to the Middle East to deal with MERS, which was very similar to the current pandemic virus.” Germfree-built facilities are in operation across the world, from resource-challenged regions to modern cities, including a high containment lab in Singapore at the forefront […]

Bio International Convention 2017

Mobile Adaptive Bioproduction Suite New Bioproduction Platform to Meet Challenges of Biotech Startups Germfree to Demonstrate Next Level in Flexible Biopharmaceutical Production SAN DIEGO, CA; June 20th, 2017 — Today, Germfree will present its Mobile Adaptive Bioproduction Suite at the BIO International Convention in San Diego. This biopharmaceutical facility is highlighted by BIO 2017 as a featured tour on the exhibition floor. The unit is the first of its kind to provide configurable space for biotech R&D and small-scale bioproduction within a self-contained mobile platform. These suites provide cGMP-compliant biomanufacturing solutions by integrating cleanrooms and biocontainment zones in a 53’ foot (16 meter) trailer. Previously, there were limited options for quickly addressing small-scale bioprocessing challenges. The Adaptive Suites deliver new options for fast, flexible and cost-effective production space that would be impractical in a brick and mortar building. Germfree’s advanced platforms are engineered to operate as stand-alone facilities and can be easily repurposed and relocated globally. In recent years, the number of new biotechnology startups has skyrocketed. However, many small-scale pharmaceutical projects lack the viable infrastructure to meet their demands. Concurrently, there has been an industry-wide shift toward more flexible manufacturing environments. “The biotech industry is under intense pressure to […]

INTERPHEX 2017

News Release For media inquiries, please contact Craig Landy – [email protected] – 386-265-4360 or 386-316-2799 First ‘Adaptive Bioproduction Suite’ to Debut at Premier BioPharma Event INTERPHEX to Showcase New Flexible Biopharmaceutical Production Platform   DAYTONA BEACH, FL; March 8th, 2017 – Germfree will introduce its Mobile Adaptive Bioproduction Suite on March 21, 2017 at International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical, biotechnology and device innovation, technology and knowledge from development through commercialization. This adaptive cleanroom trailer is the first of its kind to provide configurable space for cGMP production, R&D and biocontainment within a self-contained mobile platform. Accelerated innovation in the biopharmaceutical industry has generated a shift toward more flexible manufacturing environments. The Bioproduction Suite is a new approach for rapid deployment of cleanrooms and adaptable platforms for bioprocessing. INTERPHEX takes place March 21-23, 2017 at the Jacob Javits Center in New York, New York. The 53’ (16 meter) stand-alone cGMP facility will be featured as a special event at INTERPHEX 2017. “INTERPHEX offers the ideal venue to demonstrate technologies that represent the future of pharmaceutical and biologics development and production,” said Melissa Ashley, Senior Vice President, INTERPHEX. “We are delighted that Germfree will exhibit a mobile […]

Hospital Pharmacy Implements New Approach to Sterile Drug Compounding

RALEIGH, NC, Updated: September 29th, 2015 — Duke Raleigh Hospital recently became the first healthcare facility to utilize a certified USP 797 mobile cleanroom to assure uninterrupted pharmacy services. The advanced pharmacy unit, created by Germfree Labs, allowed the hospital to maintain separate, on-site sterile drug compounding operations during a major renovation project.

BSL-3 lab funded by Canada initiative of The Global Partnership Program Press Release

May 20, 2014 — ‘New Facility to Detect and Respond to Outbreaks of Infectious Disease’ ‘Advanced Disease Surveillance: Regional Lab Will Boost Global Biological Security’ For additional information about this news release please contact: Craig Landy: [email protected] +1 386-265-4300 Direct: +1 312-238-9785 +1 386-316-2799 Organizations Participating In This Initiative The BSL-3 lab was funded the government of Canada and is an initiative of The Global Partnership Program: Biological Security – Global Partnership Program (GPP) – Department Foreign Affairs, Trade and Development Canada: GPP “works to prevent terrorists and states of concern from acquiring or developing biological weapons and related materials, equipment, and technology.” Key roles of the program include working to: “Detect and report deliberately caused disease by strengthening regional and subregional disease surveillance and detection networks, supporting the gathering of epidemic intelligence, broadening international disease reporting networks…” The facility will be operated by CARPHA: The Caribbean Public Health Agency (CARPHA): CARPHA is the new single regional public health agency for the Caribbean. The BSL-3 Lab, the first of its kind in the region, will be run by CARPHA. Dr. C. James Hospedales is the Executive Director of the Agency. The BSL-3 laboratory was manufactured and installed by Germfree: Germfree […]

BSL-3 Lab – Zaria Nigeria Press Release

The Newest Strategy in Africa for Global Health Security Critical Outpost Deployed to Front Lines of Emerging Diseases ZARIA, NIGERIA; ORMOND BEACH, FL. –June 13th, 2010 – An unprecedented achievement within the complex arena of global health security will be unveiled in Zaria, Nigeria on June 14th. The new approach deploys high containment laboratories directly to the affected region. This provides researchers with all critical resources needed to work with highly pathogenic agents. Researchers on the ground can now provide an immediate, local response, thus containing an emerging threat before it spreads within the area of origin or to other areas of the world. The facility, to be visited Monday by the U.S. CDC Director, the U.S. Ambassador to Nigeria, and key Nigerian leaders, allows researchers to safely work with dangerous pathogens such as MDR-TB (Multi-Drug Resistant Tuberculosis). For the first time, researchers in the region can work within a ‘BSL-3’ (Biological Safety Level-3) Lab to contain these highly infectious diseases. The lab protects the researchers while ensuring that a new deadly strain cannot escape from the facility and into the environment. The new facility, funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was manufactured in modules […]

Mexico Truck Lab

FOR DISTRIBUTION TO NEWSWIRE SUBSCRIBERS ONLY Media Contacts: [email protected] Jeanne Stalzer – (+1) 386-265-4360; Craig Landy – (+1) 386-316-2799 ADDITIONAL EXPERT QUOTES Monica Heyl “In that I am currently attending the 5th Annual National Bio-Threat Conference (27-29 March 2012, Denver, Colorado); it is quite timely to hear that Germfree Laboratories, Inc. has worked with the Mexican Government on the development of their mobile public health laboratory. Global collaboration is essential in strengthening the security of nations by preventing and reducing biological threat(s), both deliberate and naturally occurring. In that Mexico and the US share almost 2000 miles of border, we are deeply connected. Providing Mexico with this public health capability contributes to our global capacity in health, disease surveillance, early warning, response, recovery and mitigation by providing one more tool in protecting the health of our world.” Monica Heyl: Recognized International Mobile Laboratory Expert. Served as the Leader of the US Army’s Mobile Laboratory & Kits (ML&K) Team and the Advanced CBRNE Training Team. Currently: Monica Heyl & Associates Olga Piña Gutiérrez “This mobile laboratory is a significant advancement for public health, providing early surveillance of potential outbreaks.” Quim. Olga Piña Gutiérrez: Director, Tabasco State Public Health Laboratory Dr. Celia […]

Germfree Logos for Media

Germfree Logos available for media use.

News Release Backgrounder

May 20, 2014 — ‘New Facility to Detect and Respond to Outbreaks of Infectious Disease’ ‘Advanced Disease Surveillance: Regional Lab Will Boost Global Biological Security’ For additional information about this news release please contact: Craig Landy: [email protected] +1 386-265-4300 Direct: +1 312-238-9785 +1 386-316-2799 Organizations Participating In This Initiative The BSL-3 lab was funded the government of Canada and is an initiative of The Global Partnership Program: Biological Security – Global Partnership Program (GPP) – Department Foreign Affairs, Trade and Development Canada: GPP “works to prevent terrorists and states of concern from acquiring or developing biological weapons and related materials, equipment, and technology.” Key roles of the program include working to: “Detect and report deliberately caused disease by strengthening regional and subregional disease surveillance and detection networks, supporting the gathering of epidemic intelligence, broadening international disease reporting networks…” The facility will be operated by CARPHA: The Caribbean Public Health Agency (CARPHA): CARPHA is the new single regional public health agency for the Caribbean. The BSL-3 Lab, the first of its kind in the region, will be run by CARPHA. Dr. C. James Hospedales is the Executive Director of the Agency. The BSL-3 laboratory was manufactured and installed by Germfree: Germfree […]

Contact Us

GERMFREE
Four Sunshine Blvd
Ormond Beach, Florida 32174
USA
+1 386-265-4360
CONTACT US